STING1 and neoplasm: TREX1 expression is initiated at a sufficient level for degrading DNA, which can accumulate in the cytosolic region of the treated tumor cell, precluding interferon (IFN-1) pathway activation induced through cyclic GMP-AMP (cGAMP) synthase (cGAs) and the associated downstream adaptor STING [28].